In a business where the management team can choose to
return capital to shareholders if returns available are not adequate, we think at worst the business is worth book value.
In a business where the management team can choose to
return capital to shareholders if returns available are not adequate, we think at worst the business is worth book value.
Not exact matches
Actual results may vary materially from those expressed or implied by forward - looking statements based on a number of factors, including, without limitation: (1) risks related
to the consummation of the Merger, including the risks that (a) the Merger may not be consummated within the anticipated time period, or at all, (b) the parties may fail
to obtain
shareholder approval of the Merger Agreement, (c) the parties may fail
to secure the termination or expiration of any waiting period applicable under the HSR Act, (d) other conditions
to the consummation of the Merger under the Merger Agreement may not be satisfied, (e) all or part of Arby's financing may not become available, and (f) the significant limitations on remedies contained in the Merger Agreement may limit or entirely prevent BWW from specifically enforcing Arby's obligations under the Merger Agreement or recovering damages for any breach by Arby's; (2) the effects that any termination of the Merger Agreement may have on BWW or its business, including the risks that (a) BWW's stock price may decline significantly
if the Merger is not completed, (b) the Merger Agreement may be terminated in circumstances requiring BWW
to pay Arby's a termination fee of $ 74 million, or (c) the circumstances of the termination, including the possible imposition of a 12 - month tail period during which the termination fee could be payable upon certain subsequent transactions, may have a chilling effect on alternatives
to the Merger; (3) the effects that the announcement or pendency of the Merger may have on BWW and its business, including the risks that as a result (a) BWW's business, operating results or stock price may suffer, (b) BWW's current plans and operations may be disrupted, (c) BWW's ability
to retain or recruit key employees may be adversely affected, (d) BWW's business relationships (including, customers, franchisees and suppliers) may be adversely affected, or (e) BWW's management's or employees» attention may be diverted from other important matters; (4) the effect of limitations that the Merger Agreement places on BWW's ability
to operate its business,
return capital to shareholders or engage in alternative transactions; (5) the nature, cost and outcome of pending and future litigation and other legal proceedings, including any such proceedings related
to the Merger and instituted against BWW and others; (6) the risk that the Merger and related transactions may involve unexpected costs, liabilities or delays; (7) other economic, business, competitive, legal, regulatory, and / or tax factors; and (8) other factors described under the heading «Risk Factors» in Part I, Item 1A of BWW's Annual Report on Form 10 - K for the fiscal year ended December 25, 2016, as updated or supplemented by subsequent reports that BWW has filed or files with the SEC.
In the long run companies must create enough cash flow
to pay expenses, invest in the future (
capital expenditures), service their debt (
if any), and
return money
to shareholders.
If you have an ownership stake in a fantastic business with great
returns on
capital, a strong competitive position that makes it difficult
to unseat in its given sector or industry, and a board of directors that is
shareholder - friendly, it shouldn't cause you any particular distress
to watch your holdings decline by 50 percent or more on paper.
If these companies have
capital to allocate, and can't reinvest it attractively in the business, make sensible acquisitions with it or pay down debt, they have
to either keep it around as cash equivalents or
return it
to shareholders.
If shareholders approve the sale of the stake
to TCCC, CCA expects
returns in Indonesia
to cover cost of
capital by 2020.
Assuming the company decides not
to pay a dividend
to the
shareholders (so the
shareholders can reinvest the money themselves), financial managers within Pfizer must identify new projects that offer a higher rate of
return than what they could get
if they simply invested the money in the financial market (this being the opportunity cost of
capital).
If those reserve requirements change then the potential
capital returned to shareholders will be reduced.
Tax policy can also influence how companies choose
to return cash
to shareholders —
if dividends are taxed at a higher rate than
capital gains, this creates incentives
to return cash via buybacks and debt reduction.
If you're invested in stocks, low interest rates typically boost the stock market because cheap
capital allows companies
to boost their bottom lines, which in turn boosts
shareholder returns.
Only time will tell
if I decide
to add
to this position but I love seeing the company continue
to return capital to its
shareholders.
If the money is paid out
to shareholders as a
return of
capital.
Once (or should I say
if) this pension / labour dispute is put
to rest, I'd actually expect a rapid & substantial improvement in
shareholder value — this might be a substantial
return of
capital or a tender offer (
to distribute surplus cash), and / or a potential new partnership or even a takeover offer..?!
If these companies have
capital to allocate, and can't reinvest it attractively in the business, make sensible acquisitions with it or pay down debt, they have
to either keep it around as cash equivalents or
return it
to shareholders.
If we hope
to see the present value gap eliminated, and Argo's intrinsic value increased, we need
to see: i) a significant level of (new) fund - raising, ii) a
return of surplus
capital to shareholders (via a value - enhancing share tender / buyback), or iii)(ideally) both!
In fact, the
return of
capital via a tender offer should also provide further reassurance:
Shareholders could be unfairly penalised
if they accepted a tender offer based on incomplete info, and / or an NAV per share that did not represent market values for all assets (& liabilities)-- potentially exposing the board / company
to legal action.
All these look good for Kingspan, so
if they utilised their «surplus» cash on an acquisition (for example), I see no risk / impairment
to the business (& no impact on their usual working
capital cycle)-- and obviously the
return for
shareholders should be far superior
to an effective zero rate on idle cash!
For instance,
if the
shareholder sells its shares, the ETF just transfers them
to the buyer, while the CEF has
to create a
capital in this case, because it have
to sell the shares in order
to return money back
to the seller.
If you have a direct / indirect shareholding in Argo Group (large or small), and would also like
to see a substantial
return of
capital to shareholders, please email me at
[email protected]
If the fund's distributions exceed its taxable income and
capital gains realized during a taxable year, all or a portion of the distributions made in the taxable year may be recharacterized as a
return of
capital to shareholders.
If a fund's distributions exceed its taxable income and
capital gains realized during a taxable year, all or a portion of the distributions made in the taxable year may be recharacterized as a
return of
capital to shareholders.
Forgone
capital expenditure can be used
to increase
shareholder cash
returns — buybacks
if management believes that the company is undervalued, dividends
if not.